Meet Cohance at
CPHI Milan 2026
Your Trusted Partner for Small Molecules, ADCs & Nucleic Acid Chemistry
- October 6-8, 2026
- Fiera Milano, Milan, Italy
- Stand #6C39
Cohance Lifesciences helps pharmaceutical innovators advance Small Molecules, ADCs, and Nucleic Acid Chemistry through an integrated CDMO platform with development-to-commercial manufacturing capabilities across India and the USA.
Trusted by top pharmaceutical innovators, we combine scientific expertise, development capabilities, and manufacturing scale on one integrated CDMO platform.
Why Cohance?
- Development to Commercial Manufacturing
- India & USA Operations
Book a meeting
Reserve a slot with our CDMO experts at the Cohance booth.
Your details are kept confidential and used only to respond to your request.
0
+
Years of CDMO Expertise
0
+
CDMO Projects Executed
0
Manufacturing Sites
0
USFDA/EDQM Accredited Sites
0
R&D Centers
0
+
Scientists
- One Platform. Three Modalities
Small Molecules. ADCs. Nucleic Acid Chemistry.
Explore what's possible at Stand #6C39.
Small Molecule · HPAPI
Small Molecule APIs
Develop, scale and manufacture complex and high-potency small molecules with regulatory confidence.
- KSMs, RSMs, intermediates & APIs across development stages
- Route scouting & process optimisation (DoE) for yield, cost and scalability
- Complex, sensitive and high-potency APIs with advanced containment
- Regulatory support for IND, IMPD and DMF filings
- Scale-up from grams to multi-tonne commercial supply
ADC & XDC
ADC & Bioconjugation
Payload, linker and bioconjugation expertise with phase-appropriate cGMP manufacturing.
- Linker–payload optimisation & bioconjugation chemistry
- Broad conjugation experience with custom and standard linkers
- High-potency containment with advanced safety controls
- Commercial payload supply including Exatecan, Camptothecin & MMAE
- Analytical development & regulatory documentation
Nucleic Acid Chemistry
Nucleosides & Phosphoramidites
Custom nucleic acid building blocks with scalable, cGMP-aligned manufacturing.
- Custom nucleoside & amidite synthesis (proprietary and modified)
- Process development & scale-up from mg to multi-kg
- cGMP manufacturing for oligonucleotide building blocks
- Late-stage development to batch production
- Flexible engagement models (FTE or fixed scope)
Reserve your slot at CPHI Milan 2026
- October 6-8, 2026
- Fiera Milano, Milan, Italy
- Stand #6C39
- Meet the team
Meet Our CDMO Leaders at CPHI Milan 2026
Yann D'Herve
CEO – CDMO
Amit Thakkar
Vice President – BD
Maximillian Yeh
VP – Sales ATMP
Andrew Donaldson
Senior Director – BD
Satish Patil
Senior Director – BD
Stefano Bolla
Senior Director – BD
TK Prakasha
Senior Director – BD
Louis Castellanos
Executive Director – BD
Ashok Kumar Jha
Head – R&D
Brianna Kempfer
Senior Director – Project Management
Jahnavi Korrapati
GM –
Project Management
Nagalakshmi S
AGM – Project Management
- Why partner with Cohance
Scientific depth, multi-modality breadth, global scale
A CRDMO partner built to carry complex programmes from early development through commercial manufacturing.
True multi-modality expertise
Small molecule APIs, ADC & bioconjugation, and nucleic acid chemistry under one charter — so pipelines evolve without switching vendors.
Global regulatory credibility
A manufacturing network audited by USFDA and EDQM, supporting submissions across regulated markets.
Built for complex chemistry
Depth in high-potency compounds, advanced ADC payloads and specialised nucleic acid building blocks.
Proven at scale
1,000+ projects delivered and 18 APIs commercialised across global markets with a reliable, back-integrated supply chain.
Scientist-led governance
Programme continuity from the chemist who designs your route to the leadership who signs your agreement.
Listed-entity transparency
A publicly listed CRDMO (NSE: SUVENPHAR) — disclosure discipline that de-risks long-horizon supply relationships.
- At the booth
What you can explore at Stand 6C39
Come with a challenge. Leave with a technical point of view. A few conversations our specialists are ready to have at CPHI Milan.
- 01
Route & process design
Route scouting, DoE optimisation and QbD process development for complex molecules.
- 02
HPAPI & containment
High-potency handling with advanced containment for sensitive chemistry.
- 03
ADC payloads & linkers
Payload platforms and bioconjugation chemistry, including Exatecan and MMAE.
- 04
Oligo building blocks
Custom nucleosides and phosphoramidites for oligonucleotide programmes.
Looking for the right CDMO partner?
Visit Stand #6C39 at CPHI Milan 2026 to discover how Cohance supports development, scale-up, and manufacturing across Small Molecules, ADCs, and Nucleic Acid Chemistry.
Book a meeting
Reserve a slot with our CDMO experts at the Cohance booth.
Your details are kept confidential and used only to respond to your request.
Collaborate. Enhance. Deliver.
Cohance Lifesciences Limited
(Formerly, Suven Pharmaceuticals Limited)
Meet us at CPHI Milan 2026
Stand 6C39 · Hall 6
6–8 October 2026
Fiera Milano · Rho · Italy
- Terms Of Use
- Privacy Policy
- © 2026 Cohance Lifesciences Ltd. All rights reserved.